Concepedia

Author

Suzanne Klise

Eli Lilly (United States)

Also Known As

S. Klise, Suzanne Klise, Suzanne R Klise, Suzanne R. Klise

21

Publications

604

Citations

12

H-Index

23

Concepts

All Affiliations

Eli Lilly (United States)Vanderbilt UniversityThe University of Texas Health Science Center at San AntonioThe University of Texas Southwestern Medical CenterDana-Farber Cancer Institute
SK

About

Suzanne Klise is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

163

2

Health Sciences

1

1

53

3

Biochemistry

1

1

21

4

Endocrinology

1

1

28

5

Neurology

1

1

15

Suzanne Klise

×

12

Publications

581

Citations

12

H-Index

YearCitations

Urodynamic Effects of Once Daily Tadalafil in Men With Lower Urinary Tract Symptoms Secondary to Clinical Benign Prostatic Hyperplasia: A Randomized, Placebo Controlled 12-Week Clinical Trial

Roger R. Dmochowski, Claus G. Roehrborn, Suzanne Klise,

The Journal of Urology

2010

126

Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study)

Jan Lewis Brandes, Suzanne Klise, John H. Krege,

Cephalalgia

2019

95

Long-Term Safety and Efficacy of Tadalafil 5 mg Dosed Once Daily in Men with Erectile Dysfunction

Hartmut Porst, Jacob Rajfer, Adolfo Casabé,

The Journal of Sexual Medicine

2008

90

Randomized, controlled trial of lasmiditan over four migraine attacks: Findings from the CENTURION study

Messoud Ashina, Uwe Reuter, Timothy R. Smith,

Cephalalgia

2021

68

Abemaciclib for the treatment of brain metastases (BM) secondary to hormone receptor positive (HR+), HER2 negative breast cancer.

Sara M. Tolaney, Nancy U. Lin, Donald Thornton,

Journal of Clinical Oncology

2017

53

Urodynamic Effects of Once Daily Tadalafil in Men With Lower Urinary Tract Symptoms Secondary to Clinical Benign Prostatic Hyperplasia: A Randomized, Placebo Controlled 12-Week Clinical Trial

Roger R. Dmochowski, Claus G. Roehrborn, Suzanne Klise,

The Journal of Urology

2012

29

Hemodynamic Effects of Once-daily Tadalafil in Men With Signs and Symptoms of Benign Prostatic Hyperplasia on Concomitant α1-Adrenergic Antagonist Therapy: Results of a Multicenter Randomized, Double-Blind, Placebo-controlled Trial

Evan R. Goldfischer, John J. Kowalczyk, William R. Clark,

Urology

2012

28

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment

Sean Wharton, Louis J. Aronne, Adam Stefański,

New England Journal of Medicine

2025

26

Assessment of concentrations of abemaciclib and its major active metabolites in plasma, CSF, and brain tumor tissue in patients with brain metastases secondary to hormone receptor positive (HR+) breast cancer.

Solmaz Sahebjam, Émilie Le Rhun, Palaniappan Kulanthaivel,

Journal of Clinical Oncology

2016

21

MONARCH 3: A randomized phase III study of anastrozole or letrozole plus abemaciclib, a CDK4/6 inhibitor, or placebo in first-line treatment of women with HR+, HER2-locoregionally recurrent or metastatic breast cancer (MBC).

Matthew P. Goetz, Masakazu Toi, Suzanne Klise,

Journal of Clinical Oncology

2015

17

Page 1